Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Corvus Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −6 vs. Q3 2022
- Shares held
- 21.4M
- −731.2K (−3.3%) vs. Q3 2022
- Total value
- $18.2M
- +$76.7K (+0.4%) vs. Q3 2022
- New holders
- 5
- 7 more added
- Sold out
- 11
- 14 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,943,654 | $5.90M | 0.11% | 00.0% | Unchanged |
| Adams Street Partners LLC | 3,275,616 | $2.78M | 0.93% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,384,402 | $2.03M | 0.54% | 00.0% | Unchanged |
| Millennium Management LLC | 1,899,516 | $1.61M | 0.00% | −365,796−16.1% | Reduced |
| BVF Inc | 1,370,947 | $1.17M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,260,566 | $1.07M | 0.00% | +660+0.1% | Added |
| Renaissance Technologies LLC | 648,632 | $551.0K | 0.00% | −326,887−33.5% | Reduced |
| Discovery Capital Management, LLC | 548,727 | $466.4K | 0.07% | +548,727 | New |
| Artal Group S.A. | 500,000 | $425.0K | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 490,781 | $417.2K | 0.00% | −12,161−2.4% | Reduced |
| Telemetry Investments, L.L.C. | 390,000 | $332.0K | 0.78% | −132,009−25.3% | Reduced |
| Geode Capital Management, LLC | 297,800 | $253.0K | 0.00% | −660−0.2% | Reduced |
| Two Sigma Investments, LP | 281,187 | $239.0K | 0.00% | −148,521−34.6% | Reduced |
| Two Sigma Advisers, LP | 260,300 | $221.3K | 0.00% | −219,800−45.8% | Reduced |
| Bridgeway Capital Management, LLC | 159,300 | $135.4K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 131,771 | $111.0K | 0.00% | −10,389−7.3% | Reduced |
| State Street Corp | 112,603 | $95.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 72,605 | $61.7K | 0.00% | +33,288+84.7% | Added |
| Jackson Square Capital, LLC | 63,773 | $54.2K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 61,668 | $52.4K | 0.00% | +9,442+18.1% | Added |
| Hikari Power Ltd | 49,959 | $42.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 30,000 | $25.5K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,459 | $21.0K | 0.00% | −11,592−31.3% | Reduced |
| Simplex Trading, LLC | 21,419 | $18.0K | 0.00% | +5,369+33.5% | Added |
| Commerce Bank | 20,000 | $17.0K | 0.00% | +20,000 | New |
| Virtu Financial LLC | 18,758 | $16.0K | 0.00% | +18,758 | New |
| Tower Research Capital LLC (TRC) | 12,718 | $11.0K | 0.00% | +1,050+9.0% | Added |
| Mercer Global Advisors Inc | 10,550 | $9.00K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 10,500 | $8.93K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,700 | $4.00K | 0.00% | −17,956−79.3% | Reduced |
| Whittier Trust Co of Nevada Inc | 4,200 | $3.57K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,201 | $1.00K | 0.00% | −1,585−56.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,750 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,015 | $863 | 0.00% | +1,015 | New |
| TCI Wealth Advisors, Inc. | 500 | $425 | 0.00% | −300−37.5% | Reduced |
| Wells Fargo & Company | 235 | $200 | 0.00% | +6+2.6% | Added |
| BNP Paribas Arbitrage, SA | 232 | $197 | 0.00% | +133+134.3% | Added |
| Bank of America Corp | 70 | $60 | 0.00% | −184−72.4% | Reduced |
| Parallel Advisors, LLC | 20 | $17 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | −1,000−90.9% | Reduced |
| IFP Advisors, Inc | 24 | – | – | +24 | New |
| Bailard, Inc. | 0 | $0 | 0.00% | −39,998−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,775−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −17,261−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −13,790−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −10,688−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −7,049−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −526−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −436−100.0% | Sold out |